EPIZYME, INC. — Net Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/acfb7d28-4e16-42d1-9b94-8fed6e84da38/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-251.1M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-002552 |
| FY 2020 | $-231.7M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-007292 |
| FY 2019 | $-170.3M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-007398 |
| FY 2018 | $-123.6M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004237 |
| FY 2017 | $-134.3M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005397 |
| FY 2016 | $-110.2M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-079460 |
| FY 2015 | $-132.4M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-497434 |
| FY 2014 | $-55.0M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-088459 |
| FY 2013 | $-3.5M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-073691 |
| FY 2012 | $-702.0k | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-073691 |
| FY 2011 | $-21.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-14-073691 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).